Asia Pacific Rare Disease Genetic Testing Market Size & Outlook
Asia Pacific rare disease genetic testing market, 2016-2028 (US$M)
Related Markets
Asia Pacific rare disease genetic testing market highlights
- The Asia Pacific rare disease genetic testing market generated a revenue of USD 134.6 million in 2020.
- The market is expected to grow at a CAGR of 11% from 2021 to 2028.
- In terms of segment, neurological disorders was the largest revenue generating disease type in 2020.
- Cancer is the most lucrative disease type segment registering the fastest growth during the forecast period.
- Country-wise, India is expected to register the highest CAGR from 2021 to 2028.
Asia Pacific data book summary
| Market revenue in 2020 | USD 134.6 million |
| Market revenue in 2028 | USD 310.8 million |
| Growth rate | 11% (CAGR from 2020 to 2028) |
| Largest segment | Neurological disorders |
| Fastest growing segment | Cancer |
| Historical data covered | 2016 - 2019 |
| Base year for estimation | 2020 |
| Forecast period covered | 2021 - 2028 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Neurological Disorders, Immunological Disorders, Hematology Diseases, Endocrine & Metabolism Diseases, Cancer, Musculoskeletal Disorders, Cardiovascular Disorders, Dermatology Disease |
| Key market players worldwide | Quest Diagnostics Inc, Centogene NV Ordinary Shares, Invitae Corp, Eurofins Scientific SE, PerkinElmer, Macrogenics Inc, Fulgent Genetics Inc, Myriad Genetics Inc, Labcorp Holdings Inc, OPKO Health Inc, 3billion, ARUP Laboratories, Strand Life Sciences, Ambry Genetics, REALM IDx, Inc., Baylor Genetics, Health Network Laboratories, PreventionGenetics, Biora Therapeutics, CooperSurgical, Artemis DNA |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 17.3% of the global rare disease genetic testing market in 2020.
- Globally, North America is projected to lead the regional market in terms of revenue in 2028.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 310.8 million by 2028.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Rare Disease Genetic Testing Market Scope
Rare Disease Genetic Testing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific rare disease genetic testing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to rare disease genetic testing market will help companies and investors design strategic landscapes.
Neurological disorders was the largest segment with a revenue share of 16.12% in 2020. Horizon Databook has segmented the Asia Pacific rare disease genetic testing market based on neurological disorders, immunological disorders, hematology diseases, endocrine & metabolism diseases, cancer, musculoskeletal disorders, cardiovascular disorders, dermatology disease covering the revenue growth of each sub-segment from 2016 to 2028.
With improving doctor awareness and diagnosis abilities, the status of rare disease in region is expected to change. Nearly two-thirds of the world’s population reside in Asian countries, thus availability of target population is highest in this country. Several country lacks proper legal framework to combat rare disease.
Introduction of policies and framework to promote rare disease management is the key to shape the market dynamics. Furthermore, presence of a substantial number of organizations that are focusing on rare disease management is positively influencing the revenue growth in the region.
For instance, Fragile X Society India, Indian Association of Muscular Dystrophy, Pompe Foundation, Indian Prader-Willi Syndrome Association, Genetic Alliance, and Hemophilia Federation are some of the Indian organizations that aimed to support management of rare disease in the country, thereby contributing to the growth of Asian market.
Reasons to subscribe to Asia Pacific rare disease genetic testing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific rare disease genetic testing market databook
-
Our clientele includes a mix of rare disease genetic testing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific rare disease genetic testing market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific rare disease genetic testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific rare disease genetic testing market size, by country, 2016-2028 (US$M)
Asia Pacific Rare Disease Genetic Testing Market Outlook Share, 2020 & 2028 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
